Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.
Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.
复制标题
DOI:
10.1002/hep.28680
复制
发表时间:
2016-10
期刊:
影响因子:
13.5
通讯作者:
Szabo, Gyongyi
中科院分区:
文献类型:
--
作者:
Bukong, Terence N.;Iracheta-Vellve, Arvin;Saha, Banishree;Ambade, Aditya;Satishchandran, Abhishek;Gyongyosi, Benedek;Lowe, Patrick;Catalano, Donna;Kodys, Karen;Szabo, Gyongyi
The spectrum of alcoholic liver disease (ALD) is a major cause of mortality with limited therapies available. Because alcohol targets numerous signaling pathways in hepatocytes and in immune cells, the identification of a master regulatory target that modulates multiple signaling processes is attractive. In this report, we assessed the role of spleen tyrosine kinase (SYK), a non-receptor tyrosine kinase, which has a central modulatory role in multiple pro-inflammatory signaling pathways involved in the pathomechanism of ALD. Using mouse disease models that represent various phases in the progression of human ALD, we found that alcohol, in all of these models, induced SYK activation in the liver, both in hepatocytes and liver mononuclear cells. Further, significant SYK activation also occurred in liver samples and peripheral blood mononuclear cells of patients with ALD/alcoholic hepatitis compared to controls. Functional inhibition of SYK activation in vivo abrogated alcohol-induced hepatic neutrophil infiltration, resident immune cell activation, as well as inflammasome and ERK1/2-mediated NF-κB activation in mice. Strikingly, inhibition of SYK activation diminished alcohol-induced hepatic steatosis and IRF3-mediated apoptosis. Our data demonstrate a novel, functional, and multicellular role for SYK phosphorylation in modulating immune cell-driven liver inflammation, hepatocyte cell death, and steatosis at different stages of ALD. These novel findings highlight SYK as a potential multifunctional target in the treatment of alcoholic steatohepatitis.
登录
查看更多内容
影响因子:
8
作者:
Lee CK;Yang Y;Chen C;Liu J
通讯作者:
Liu J
DOI:
10.1124/jpet.106.109058
发表时间:
2006-12-01
影响因子:
3.5
作者:
Braselmann, Sylvia;Taylor, Vanessa;Masuda, Esteban S.
通讯作者:
Masuda, Esteban S.
DOI:
10.2174/187221312800166895
发表时间:
2012-01-01
影响因子:
4.2
作者:
Moretto, Alessandro F.;Dehnhardt, Christoph;Thorarensen, Atli
通讯作者:
Thorarensen, Atli
影响因子:
13.5
作者:
Bukong, Terence N.;Kodys, Karen;Szabo, Gyongyi
通讯作者:
Szabo, Gyongyi
DOI:
10.1111/j.1530-0277.2010.01399.x
发表时间:
2011-05
期刊:
Alcoholism, clinical and experimental research
影响因子:
--
作者:
Miller AM;Horiguchi N;Jeong WI;Radaeva S;Gao B
通讯作者:
Gao B